BioCentury
ARTICLE | Finance

Gassing up for royalties

How Royalty Pharma will spend its newly raised $1 billion

May 18, 2015 7:00 AM UTC

Royalty Pharma has refilled its tank with a $1 billion equity raise and plans to use a portion of the money to ramp up its search for royalty streams from sources other than marketed products.

The firm emptied more than half of its coffers in November 2014 when it paid the Cystic Fibrosis Foundation $3.3 billion for CFF's rights to royalties from cystic fibrosis (CF) treatments developed by Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)...